Picture of LifeMD logo

LFMD LifeMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

LifeMD Inc reports results for the quarter ended in September - Earnings Summary

* LifeMD Inc  LFMD.OQ  reported a quarterly adjusted loss
of 26
cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 28
cents per share.
    * Revenue rose 25.9% to $31.41 million from a year ago;
analysts
expected $31.84 million. 
    * LifeMD Inc's reported EPS for the quarter was a loss of 26
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * LifeMD Inc shares had risen by 2.0% this quarter and
lost 48.1%
so far this year.
    * The company reported a quarterly loss of $8.06 million.
    * Wall Street's median 12-month price target for LifeMD Inc
is
$8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.28          -0.26          Beat
 Jun. 30 2022      -0.35          -0.45          Missed
 Mar. 31 2022      -0.36          -0.46          Missed
 Dec. 31 2021      -0.42          -0.62          Missed

Recent news on LifeMD

See all news